Austedo 9 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DR26FV5X9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,586
Award facts
- Contract value 100% obligated
- $25,585.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $25,585.81 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Austedo 9 mg, a medication used to treat movement disorders. This firm fixed-price contract, awarded on November 10, 2025, with an ultimate completion date of November 12, 2025, represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The award was made through open competition with no set-aside designation, reflecting the contractor's demonstrated capability to meet federal procurement standards. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania facility, which serves as the company's corporate headquarters and primary distribution center for federal medical supply contracts.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive relationship with the Defense Logistics Agency through its $999,999,999.00 indefinite delivery contract (designated SPE2DX) that extends through December 2026. This comprehensive pharmaceutical prime vendor agreement enables the company to supply a broad range of medications and medical products to support military healthcare programs globally. The current Austedo delivery order exemplifies AmerisourceBergen's ongoing role in providing specialty medications and brand-name pharmaceuticals to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard, through competitively awarded transactions with firm fixed pricing.
Quick answers
Who was awarded contract SPE2DR26FV5X9?
SPE2DR26FV5X9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DR26FV5X9 worth?
The government has obligated $25,586 on SPE2DR26FV5X9.
Is contract SPE2DR26FV5X9 an order under another contract?
Yes. SPE2DR26FV5X9 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FV5X9 competed?
The extent of competition for SPE2DR26FV5X9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award